Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Jan 21, 2020 10:39 AM IST | Source: PTI

USFDA inspects Alembic Pharma's facility in Karkhadi, Gujarat

"The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals active pharmaceutical ingredient (API) facility located at Karkhadi from January 13 to January 17, 2020," it said.

Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Alembic Pharmaceuticals on Tuesday said the US health regulator has conducted an inspection at its facility in Karkhadi, Gujarat. At the end of the inspection, the USFDA issued a form 483 with two observations, the drug firm said in a filing to BSE.

"The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals active pharmaceutical ingredient (API) facility located at Karkhadi from January 13 to January 17, 2020," it said.

This was a scheduled pre-approval inspection.

Close
The shares of the company were trading at Rs 600.30 a piece on BSE in morning trade, up 0.26 percent from the previous close.

Subscribe to Moneycontrol Pro's Annual plan for Rs 399/- for the first year. Use coupon PRO2020 (Available on Web & Android only).

First Published on Jan 21, 2020 10:37 am
Sections
Follow us on